1. 2703 Computed tomography is more sensitive than CA 125 in detecting disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial. (September 2015) Authors: Lindeman, K.; Kristensen, G.; Raza Mirza, M.; Davies, L.; Hilpert, F.; Romero, I.; Ayhan, A.; Burges, A.; Rubio, M.J.; Raspagliesi, F.; Huizing, M.; Creemers, G.J.; Lykka, M.; Lee, C.; Gebski, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COMBINATION OF PEGLIPOSOMAL DOXORUBICIN (PLD) AND CARBOPLATIN IN GYNECOLGIC TUMORS - AN AGO STUDY GROUP PHASE I/II TRIAL. Issue 1 (1st March 2003) Authors: Gropp, M.; duBois, A.; Burges, A.; Meier, W. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗